Literature DB >> 1341721

Role of pineal melatonin and melatonin-induced-immuno-opioids in murine leukemogenesis.

A Conti1, N Haran-Ghera, G J Maestroni.   

Abstract

The relationship between the pineal gland, melatonin and melatonin-induced-immuno-opioids with the response of C57Bl/6 mice to A-RadLV induced T cell lymphomas was investigated. Mice were injected at day 0 with A-RadLV and from day 10 they were treated chronically with melatonin 4 mg/kg body weight, naltrexone 1 mg/kg or phosphate buffered saline, throughout the experiment. In another protocol, groups of mice were a) surgical pinealectomized at day-14, b) functional pinealectomized (24:24 hours light) from day -20 and c) sham pinealectomized. At day 0 each group was inoculated intrathymically with A-RadLV. The results show that melatonin accelerated (p < 0.005) leukemogenesis whereas the surgical pinealectomy and the functional pinealectomy delayed it (p < 0.005 and p < 0.01). Moreover, the action of melatonin was blocked by naltrexone (p < 0.005), indicating the involvement of melatonin-induced-immuno-opioids in the development of the lymphomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1341721     DOI: 10.1007/bf02989659

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  16 in total

1.  Characteristics of potential lymphoma-inducing cells in mice sensitive or resistant to lymphomagenesis by radiation leukemia virus variants.

Authors:  I Gokhman; A Peled; N Haran-Ghera
Journal:  Cancer Res       Date:  1990-05-01       Impact factor: 12.701

2.  Anti-stress role of the melatonin-immuno-opioid network: evidence for a physiological mechanism involving T cell-derived, immunoreactive beta-endorphin and MET-enkephalin binding to thymic opioid receptors.

Authors:  G J Maestroni; A Conti
Journal:  Int J Neurosci       Date:  1991-12       Impact factor: 2.292

3.  The cellular basis of immunosuppression caused by the radiation leukaemia virus.

Authors:  A Peled; N Haran-Ghera
Journal:  Immunology       Date:  1974-02       Impact factor: 7.397

4.  Chronological appearance of alkaline phosphatase activity in virus-induced thymic lymphomas of C57BL-6 mice.

Authors:  K J Wilson; H Neumann; N Haran-Ghera
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

5.  Sleep-promoting effects of endogenous pyrogen (interleukin-1).

Authors:  J M Krueger; J Walter; C A Dinarello; S M Wolff; L Chedid
Journal:  Am J Physiol       Date:  1984-06

6.  Latent period in leukaemia induction by the radiation leukaemia virus.

Authors:  N Haran-Ghera
Journal:  Nat New Biol       Date:  1972-07-05

7.  Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. II. Analysis of the immune response.

Authors:  N Haran-Ghera; N Rubio
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

8.  Role of the pineal gland in immunity: II. Melatonin enhances the antibody response via an opiatergic mechanism.

Authors:  G J Maestroni; A Conti; W Pierpaoli
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

9.  The pineal neurohormone melatonin stimulates activated CD4+, Thy-1+ cells to release opioid agonist(s) with immunoenhancing and anti-stress properties.

Authors:  G J Maestroni; A Conti
Journal:  J Neuroimmunol       Date:  1990-07       Impact factor: 3.478

10.  Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone.

Authors:  G J Maestroni; A Conti; W Pierpaoli
Journal:  J Neuroimmunol       Date:  1986-11       Impact factor: 3.478

View more
  4 in total

Review 1.  The role of melatonin in immuno-enhancement: potential application in cancer.

Authors:  Sandra C Miller; S R Pandi-Perumal; Perumal S R Pandi; Ana I Esquifino; Daniel P Cardinali; Georges J M Maestroni
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

2.  Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults.

Authors:  Nalaka S Gooneratne; Alena Y Z Edwards; Chen Zhou; Norma Cuellar; Michael A Grandner; Jeffrey S Barrett
Journal:  J Pineal Res       Date:  2012-02-21       Impact factor: 13.007

Review 3.  Melatonin: does it have utility in the treatment of haematological neoplasms?

Authors:  Tian Li; Zhi Yang; Shuai Jiang; Wencheng Di; Zhiqiang Ma; Wei Hu; Fulin Chen; Russel J Reiter; Yang Yang
Journal:  Br J Pharmacol       Date:  2017-09-09       Impact factor: 8.739

4.  Impaired mouse mammary gland growth and development is mediated by melatonin and its MT1G protein-coupled receptor via repression of ERα, Akt1, and Stat5.

Authors:  Shulin Xiang; Lulu Mao; Lin Yuan; Tamika Duplessis; Frank Jones; Gary W Hoyle; Tripp Frasch; Robert Dauchy; David E Blask; Geetika Chakravarty; Steven M Hill
Journal:  J Pineal Res       Date:  2012-05-14       Impact factor: 13.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.